SCHD
Schwab U.S. Dividend Equity ETF
SCHD tracks the Dow Jones U.S. Dividend 100 Index, focusing on high dividend yield with rigorous quality screens. Requires 10+ years of dividend payments and screens for financial health metrics. Diversified across 11 sectors with healthcare as its largest allocation.
XLV
Health Care Select Sector SPDR Fund
XLV tracks the Health Care Select Sector Index, providing pure exposure to healthcare companies within the S&P 500. Includes pharmaceuticals, biotechnology, healthcare equipment, healthcare services, and healthcare technology. 100% healthcare sector exposure.
Key Metrics Comparison
| Metric | SCHD | XLV | Winner |
|---|---|---|---|
| Dividend Yield | 3.27% | 1.52% | SCHD (+1.94%) |
| Expense Ratio | 0.06% | 0.10% | SCHD (-0.04%) |
| 5-Year Annual Return | 11.2% | 13.5% | XLV (+2.3%) |
| Number of Holdings | 104 | 65 | SCHD |
| Assets Under Management | $95.2B | $41.8B | SCHD |
| P/E Ratio | 15.2 | 22.5 | SCHD |
| Volatility (5-Year) | 15.2% | 16.8% | SCHD (-1.6%) |
| Sector Concentration | 11 Sectors | 1 Sector | Different Strategies |
Performance Comparison
SCHD Performance
Strong total returns with significantly higher income. Quality screens provide defensive characteristics. Multi-sector diversification reduces single sector risk. Healthcare is largest sector at 18.5% but not dominant.
XLV Performance
Higher total returns with lower income. Pure healthcare sector exposure benefits from demographic trends and innovation. Sector concentration provides focused growth but with sector-specific risks.
Strategy Analysis
SCHD Approach
Multi-sector quality dividend growth:
- Minimum 10 years of dividend payments
- Dividend yield > 2.5% requirement
- Cash flow to total debt > 50%
- Return on equity > 15%
- Market cap > $500 million
- Diversified across 11 sectors
- Healthcare is largest sector (18.5%)
- Quality growth with income focus
XLV Approach
Pure healthcare sector exposure:
- 100% healthcare sector focus
- S&P 500 healthcare companies
- Pharmaceuticals, biotech, equipment
- Healthcare services and technology
- Market-cap weighted within sector
- Demographic tailwind exposure
- Innovation and research focus
- Defensive sector characteristics
Sector Concentration Analysis
SCHD offers multi-sector diversification (11 sectors, healthcare 18.5%) with quality screens, while XLV provides pure sector focus (100% healthcare). This represents the classic diversification vs concentration tradeoff.
SCHD Healthcare
SCHD Financials
XLV Healthcare
Number of Sectors
Healthcare Subsector Breakdown (XLV)
XLV provides comprehensive exposure across all healthcare subsectors, with pharmaceuticals as the largest component. This diversified healthcare exposure includes both defensive (pharma) and growth (biotech) segments.
Pharmaceuticals
40% of XLV: Large-cap drug manufacturers
Examples: Johnson & Johnson, Pfizer, Merck
Characteristics: Defensive, stable dividends
Risk: Patent cliffs, regulation
Healthcare Equipment
22% of XLV: Medical devices and equipment
Examples: Abbott Labs, Medtronic, Boston Scientific
Characteristics: Innovation-driven growth
Risk: Regulatory approval cycles
Biotechnology
18% of XLV: Biotech research companies
Examples: Amgen, Gilead, Vertex
Characteristics: High growth potential
Risk: Clinical trial failures
Defensive Characteristics
Defensive Profile Comparison
Both SCHD and XLV offer defensive characteristics but through different mechanisms: SCHD through quality screens and dividend sustainability, XLV through healthcare sector's recession-resistant nature.
SCHD Beta
XLV Beta
2008 Performance
2020 Performance
Demographic Tailwinds (XLV Advantage)
Healthcare benefits from powerful demographic trends that provide secular growth tailwinds independent of economic cycles.
Aging Population
10,000 baby boomers turn 65 daily in US
Healthcare spending increases with age
Chronic disease prevalence rises with age
Multi-decade demographic trend
Innovation Cycle
Biotech breakthroughs (mRNA, gene therapy)
Medical device innovation (robotics, AI)
Pharmaceutical R&D continues to advance
Healthcare digitization accelerates
Economic Characteristics
Recession-resistant: Healthcare is necessity
Pricing power: Limited healthcare alternatives
Regulatory moats: FDA approvals create barriers
Global demand: Universal healthcare need
Income Analysis
SCHD Income Profile
Higher yield from multi-sector quality dividend payers. Focus on sustainable dividends from financially healthy companies across sectors. Strong dividend growth from quality companies.
XLV Income Profile
Lower yield from growth-focused healthcare sector. Many healthcare companies reinvest profits into R&D rather than dividends. Some pharmaceutical companies offer solid dividends but biotech typically does not.
Risk Analysis
SCHD Risk Profile
Multi-sector diversification reduces specific risks:
- Sector concentration risk: Low (max 18.5% healthcare)
- Regulatory risk: Spread across sectors
- Dividend cut risk: Mitigated by quality screens
- Interest rate sensitivity: Moderate
- Economic cycle risk: Balanced across sectors
- Company-specific risk: Diversified (104 holdings)
- Quality risk: Addressed by financial screens
- Overall risk: Lower due to diversification
XLV Risk Profile
Sector concentration creates specific risks:
- Sector concentration risk: High (100% healthcare)
- Regulatory risk: High (FDA, Medicare policies)
- Patent cliff risk: Pharma specific
- Clinical trial risk: Biotech specific
- Political risk: Healthcare reform debates
- Pricing pressure risk: Drug pricing legislation
- Innovation risk: R&D failure rates
- Overall risk: Higher due to concentration
Top Holdings Comparison
SCHD Top Holdings (Multi-Sector Quality)
Note: Healthcare represents 2 of top 5 holdings but only 18.5% of total portfolio
XLV Top Holdings (Pure Healthcare)
Note: Top 10 holdings represent ~55% of portfolio, showing concentration in large-cap healthcare
Investment Recommendation
🎯 Choose SCHD If:
- Higher current income is important (3.27% vs 1.52%)
- Multi-sector diversification appeals to you
- Lower costs matter (0.06% vs 0.10%)
- Dividend growth is a priority (8.5% vs 6.8%)
- You want quality screens and financial health filters
- Sector concentration risk concerns you
- You prefer balanced exposure across economic sectors
- Lower volatility is desirable (15.2% vs 16.8%)
🏥 Choose XLV If:
- Higher total returns matter (13.5% vs 11.2%)
- You believe in healthcare demographic tailwinds
- Defensive sector exposure appeals to you
- You want pure healthcare sector exposure
- Innovation and medical advances excite you
- You can handle sector concentration risk
- Lower current income is acceptable
- You want recession-resistant characteristics
💡 Portfolio Construction Strategy
Most investors benefit from using SCHD as their core dividend holding (60-70% of dividend allocation) and adding XLV as a satellite healthcare position (10-20%). This provides quality dividend growth with targeted healthcare exposure. For healthcare-focused investors: 50% SCHD + 30% XLV + 20% other sectors. For maximum diversification: 80% SCHD + 20% XLV. Note that SCHD already has 18.5% healthcare exposure, so adding XLV increases healthcare concentration. Consider your overall portfolio healthcare exposure before adding XLV.